← All stocks

Yarrow Bioscience, Inc.

YARW No buying or selling
CIK 0001566044 #4323 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions
1.5×

David Domzalski holds only 1.5 times base salary in stock. $1.01M of shares against $637.56K in salary for 2024.

Salary from the company's own proxy. The shares are what David Domzalski last reported holding, valued at $2.92, the price Common Stock was last bought or sold at on the open market here, on 15 Jan 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Domzalski David
PRESIDENT AND CEO
347,174
$1.01M
−31.0%
RTW Fund Group GP, LLC entity
10% owner
266,307
$777.62K
−33.4%
Stuart Iain
CHIEF SCIENTIFIC OFFICER
95,944
$280.16K
−28.9%
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
95,918
$280.08K
−35.7%
Zeronda Tyler
Director
74,918
$218.76K
−43.6%
LEPORE PATRICK G
Director
51,472
$150.30K
+41.1%

No percentages here. This company's share count has moved by a factor of 12.5 over the window, from 2,669,746 to 33,352,858 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 399,242
History held since 29 Jan 2018